Treats acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. ANDA 71868, held by Hospira. Cytarabine.
As of Nov 16, 2026, ANDA 71868 (Cytarabine), held by Hospira, was first approved by FDA on Jun 4, 1990, with 19 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Cytarabine Injection in combination with other approved anti-cancer drugs is indicated for remission induction in acute non-lymphocytic leukemia of adults and pediatric patients. It has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia. Intrathecal administration of Cytarabine Injection (preservative free preparations only) is indicated in the prophylaxis and treatment of meningeal leukemia.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 4, 1990 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cytarabine20MG/ML · injectable;injection | Cytarabine | Rx |
| Jul 29, 2026 | Supplement 38Labeling · Standard review | Approved | None posted |
| Jun 2, 2020 | Supplement 32Labeling · Standard review | Approved | |
| Jan 15, 2019 | Supplement 31Labeling · Standard review | Approved | None posted |
| Jan 15, 2019 | Supplement 30Labeling · Standard review | Approved | None posted |
| Jan 15, 2019 | Supplement 29Labeling · Standard review | Approved | None posted |
| May 14, 2001 | Supplement 17Manufacturing | Approved | None posted |
| Aug 8, 2000 | Supplement 15Manufacturing | Approved | None posted |
| May 18, 2000 | Supplement 14Manufacturing | Approved | None posted |
| May 12, 2000 | Supplement 13Manufacturing | Approved | None posted |
| Mar 28, 1998 | Supplement 11Manufacturing | Approved | None posted |
| Jun 2, 1997 | Supplement 9Labeling | Approved | None posted |
| Apr 16, 1997 | Supplement 8Manufacturing | Approved | None posted |
| Apr 28, 1995 | Supplement 7Manufacturing | Approved | None posted |
| Sep 23, 1994 | Supplement 5Labeling | Approved | None posted |
| May 23, 1994 | Supplement 6Manufacturing | Approved | None posted |
| May 28, 1993 | Supplement 3Manufacturing | Approved | None posted |
| Mar 25, 1991 | Supplement 4Manufacturing | Approved | None posted |
| Jan 15, 1991 | Supplement 2Manufacturing | Approved | None posted |
| Dec 31, 1990 | Supplement 1Manufacturing | Approved | None posted |
| Jun 4, 1990 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters